Bo‐Dou Zhang

621 total citations
26 papers, 504 citations indexed

About

Bo‐Dou Zhang is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Bo‐Dou Zhang has authored 26 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Immunology and 4 papers in Biomedical Engineering. Recurrent topics in Bo‐Dou Zhang's work include Immunotherapy and Immune Responses (8 papers), interferon and immune responses (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Bo‐Dou Zhang is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), interferon and immune responses (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Bo‐Dou Zhang collaborates with scholars based in China, Japan and Israel. Bo‐Dou Zhang's co-authors include Yanmei Li, Jun Wu, Wenhao Li, Hong‐Guo Hu, Zhanyi Sun, Lang Zhao, Dongsheng Liu, Yu Shao, Yijie Wang and Yong‐Xiang Chen and has published in prestigious journals such as Advanced Materials, Biomaterials and Chemical Communications.

In The Last Decade

Bo‐Dou Zhang

20 papers receiving 495 citations

Peers

Countries citing papers authored by Bo‐Dou Zhang

Since Specialization

Citations

This map shows the geographic impact of Bo‐Dou Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo‐Dou Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo‐Dou Zhang more than expected).

Fields of papers citing papers by Bo‐Dou Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo‐Dou Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo‐Dou Zhang. The network helps show where Bo‐Dou Zhang may publish in the future.

Co-authorship network of co-authors of Bo‐Dou Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Bo‐Dou Zhang. A scholar is included among the top collaborators of Bo‐Dou Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo‐Dou Zhang. Bo‐Dou Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ryanodane diterpenes: occurrence, structural diversity, bioactivities, and synthesis 2025 ·Natural Product Reports ·Bo‐Dou Zhang, Jingwen Zhao, Sheng Li, Hong Liang, Xiao‐Jiang Hao, (unknown)	0
2	Bioassay-guided and DeepSAT + SMART-driven identification of hepatoprotective phenolics from the fruits of Phyllanthus emblica 2025 ·Fitoterapia ·(unknown), Sheng Li, Hui Wang, (unknown), Bo‐Dou Zhang, (unknown), (unknown), Ning Li, Yu Zhang	1
3	Rationally designed anti-autophagy nanosystems for reversing the immunosuppressive network in the tumor environment 2025 ·Nanomedicine ·Bo‐Dou Zhang, Xi Chen, (unknown), (unknown), (unknown), Jun Wu, Wenhao Li, Tianyang Wang, Ling Liu, (unknown), (unknown), Yufen Zhao, Yanmei Li	0
4	The structures and regulatory roles of natural products in lipid metabolism: focus on medicinal and edible plants 2024 ·Food Science and Human Wellness ·Xinjian Zhang, Li Sheng, Bo‐Dou Zhang, (unknown)	0
5	Hypecotumines A-D, new isoquinoline alkaloids with potential PCSK9 inhibition activity from Hypecoum erectum L. 2024 ·Natural Products and Bioprospecting ·(unknown), (unknown), (unknown), Bo‐Dou Zhang, Xiaoyu Li, Sheng Li, (unknown), (unknown), (unknown)	0
6	The application and perspective of NMR and MS based strategies for functional compounds mining in medicinal and dietary plants 2024 ·Food Science and Human Wellness ·Bo‐Dou Zhang, Sheng Li, (unknown), (unknown), (unknown), (unknown), (unknown), Xiao‐Jiang Hao, Yu Zhang	6
7	Mining of antioxidant sesquiterpene lactones from the aerial parts of Saussurea involucrata with feature-based molecular network strategy 2024 ·Bioorganic Chemistry ·Bo‐Dou Zhang, (unknown), Jingwen Zhao, Sheng Li, Yong Sun, Lijun Fu, (unknown), Wenyi Kang, Yu Zhang	1
8	Corydecusines A-H, new phthalideisoquinoline hemicetal alkaloids from the bulbs of Corydalis decumbens inhibit Tau pathology by activating autophagy mediated by AMPK-ULK1 pathway 2024 ·Bioorganic Chemistry ·Sheng Li, Rongcan Luo, Zhenzhen Liang, Bo‐Dou Zhang, (unknown), (unknown), Jing Dong, Xiaoyu Li, (unknown), Xiao‐Jiang Hao, Ning Li, Yu Zhang	7
9	Myeloid Cell‐Triggered In Situ Cell Engineering for Robust Vaccine‐Based Cancer Treatment 2024 ·Advanced Materials ·Wenhao Li, Jingyun Su, Bo‐Dou Zhang, Lang Zhao, (unknown), (unknown), Hong‐Guo Hu, Yanmei Li	6
10	Cyclic Dinucleotide Self-Assembled Nanoparticles as a Carrier-Free Delivery Platform for STING-Mediated Cancer Immunotherapy 2023 ·CCS Chemistry ·(unknown), (unknown), Tianyang Wang, Jun Wu, Jingyun Su, Wenhao Li, Bo‐Dou Zhang, Yanmei Li	13
11	Cardiac glycosides from the roots of Streblus asper Lour. with activity against Epstein-Barr virus lytic replication 2022 ·Bioorganic Chemistry ·Jing Cai, Bo‐Dou Zhang, (unknown), (unknown), Toshihiro Akihisa, Takashi Kikuchi, Jian Xu, Wenyuan Liu, Feng Feng, Jie Zhang	3
12	STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation 2022 ·Nano Research ·Bo‐Dou Zhang, Jun Wu, Wenhao Li, Hong‐Guo Hu, Lang Zhao, (unknown), Yufen Zhao, Yanmei Li	41
13	Black phosphorous nanosheet: A novel immune-potentiating nanoadjuvant for near-infrared-improved immunotherapy 2021 ·Biomaterials ·Wenhao Li, Jun Wu, Lie Wu, Bo‐Dou Zhang, Hong‐Guo Hu, Lang Zhao, Zhibin Li, Xue‐Feng Yu, Yanmei Li	52
14	Sauropus androgynus L. Merr.-A phytochemical, pharmacological and toxicological review 2020 ·Journal of Ethnopharmacology ·Bo‐Dou Zhang, (unknown), Chaofeng Zhang, (unknown), Wenyuan Liu, Wei Li, Kazuo Koike, Toshihiro Akihisa, Feng Feng, Jie Zhang	35
15	Cardiac glycosides from the roots of Streblus asper Lour. and their apoptosis-inducing activities in A549 cells 2020 ·Phytochemistry ·Bo‐Dou Zhang, (unknown), Toshihiro Akihisa, Takashi Kikuchi, Motohiko Ukiya, (unknown), Jian Xu, Wenyuan Liu, Feng Feng, Jie Zhang	11
16	Pam₃CSK₄-CDG^SF Augments Antitumor Immunotherapy by Synergistically Activating TLR1/2 and STING 2020 ·Bioconjugate Chemistry ·Hong‐Guo Hu, Jun Wu, Bo‐Dou Zhang, Wenhao Li, Yanmei Li	21
17	Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of α-Synuclein Amyloids in Parkinson's Disease 2019 ·Frontiers in Molecular Biosciences ·Ashim Paul, Bo‐Dou Zhang, (unknown), Li Gao, Yanmei Li, Ehud Gazit, Daniel Segal	42
18	Regulation of Immune Activation by Optical Control of TLR1/2 Heterodimerization 2019 ·ChemBioChem ·Hong‐Guo Hu, Pu‐Guang Chen, Guanyu Wang, Jun Wu, Bo‐Dou Zhang, Wenhao Li, Rebecca L. Davis, Yanmei Li	10
19	Designable Immune Therapeutical Vaccine System Based on DNA Supramolecular Hydrogels 2018 ·ACS Applied Materials & Interfaces ·Yu Shao, Zhanyi Sun, Yijie Wang, Bo‐Dou Zhang, Dongsheng Liu, Yanmei Li	101
20	Targeting STING with cyclic di-GMP greatly augmented immune responses of glycopeptide cancer vaccines 2018 ·Chemical Communications ·Jun Wu, Wenhao Li, Pu‐Guang Chen, Bo‐Dou Zhang, Hong‐Guo Hu, Qianqian Li, Lang Zhao, Yong‐Xiang Chen, Yufen Zhao, Yanmei Li	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact